Nicoletta Brunello

Nicoletta Brunello

Auto-generated profile, based on publicly available information

Nicoletta Brunello

Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy

Research Focus & Metrics

Academic Career Length

50Years (1977-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 1998 in European Neuropsychopharmacology
Verified
Journal Article
Closed access
JKJohn M Kane
John M Kane
Eugenio AgugliaEugenio Aguglia
Eugenio Aguglia
AAA.CArlo Altamura
A.CArlo Altamura
JGJosé Luis Ayuso Gutierrez
José Luis Ayuso Gutierrez
NBNicoletta Brunello
Nicoletta Brunello
NSNina R Schooler
Nina R Schooler

1 March 2001 in Neuropsychobiology
Verified
Journal Article
Closed access
PDF file
NBNicoletta Brunello
Nicoletta Brunello
JDJonathan R.T. Davidson
Jonathan R.T. Davidson
MDMartin Deahl
Martin Deahl
RKRon C. Kessler
Ron C. Kessler
JMJulien Mendlewicz
Julien Mendlewicz
JZJoseph Zohar
Joseph Zohar
Epidemiological studies clearly indicate that posttraumatic stress disorder (PTSD) is becoming a major health concern worldwide even if still poorly recognized and not well treated. PTSD commonly co-occurs with other psychiatric disorders, and several symptoms overlap with major depressive disorders, anxiety disorders and substance abuse; this may contribute to diagnostic confusion and underdiagnosis. This anxiety disorder provokes significant occupational, psychiatric, medical and psychosocial disability, and its consequences are enormously costly, not only to the survivors and their families, but also to the health care system and society. Work impairment associated with PTSD is very similar to the amount of work impairment associated with major depression. The pathophysiology of PTSD is multifactorial and involves dysregulation of the serotonergic as well as the noradrenergic system. A rational therapeutic approach should normalize the specific psychobiological alterations associated with PTSD. This can be achieved through the use of antidepressant drugs, mainly of those that potentiate serotonergic mechanisms. Recent double-blind placebo-controlled studies report the efficacy of selective serotonin reuptake inhibitors. Several cognitive-behavioral and psychosocial treatments have also been reported to be efficacious and could be considered when treating PTSD patients.

1 July 2006 in International Clinical Psychopharmacology
Verified
Journal Article
Closed access
JMJulien Mendlewicz
Julien Mendlewicz
PKPhilippe Kriwin
Philippe Kriwin
POPierre Oswald
Pierre Oswald
DSDaniel Souery
Daniel Souery
Silvia AlboniSilvia Alboni
Silvia Alboni
NBNicoletta Brunello
Nicoletta Brunello
Based on our preclinical data showing a potential accelerating effect of acetylsalicylic acid (ASA) in combination with fluoxetine in an animal model of depression, we examined the effect of ASA augmentation therapy on selective reuptake inhibitors (SSRI) in major depressed non-responder patients. Twenty-four non-responder patients having received at least 4 weeks of an adequate SSRI treatment were included in a pilot open-label study. Participants were treated openly during 4 weeks with 160 mg/day ASA in addition to their current antidepressant treatment. The combination SSRI–ASA was associated with a response rate of 52.4%. Remission was achieved in 43% of the total sample and 82% of the responder sample. In the responder group, a significant improvement was observed within week 1 (mean Hamilton Depression Rating Scale-21 items at day 0=29.3±4.5, at day 7=14.0±4.1; P<0.0001) and remained sustained until day 28. Despite limitations due to the open nature of this study, our preliminary results confirm our preclinical findings and are in favour of an accelerating effect of ASA in combination with SSRIs in the treatment of major depression. Potential physiological and biochemical mechanisms may involve an anti-inflammatory and/or neurotrophic effect.

1 November 1982 in Neuropharmacology
Verified
Journal Article
Closed access
NBN Brunello
N Brunello
MBM Barbaccia
M Barbaccia
DCD Chuang
D Chuang
ECE Costa
E Costa

1 October 2002 in European Neuropsychopharmacology
Verified
Journal Article
Closed access
NBN Brunello
N Brunello
JMJ Mendlewicz
J Mendlewicz
SKSiegfried Kasper
Siegfried Kasper
BLB Leonard
B Leonard
SMS Montgomery
S Montgomery
GRG Racagni
G Racagni

1 June 1978 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
FPFranca Ponzio
Franca Ponzio
NBNicoletta Brunello
Nicoletta Brunello
SAS. Algeri
S. Algeri